A Practical Approach to the Management of Residual Cardiovascular Risk: United Arab Emirates Expert Consensus Panel on the Evidence for Icosapent Ethyl and Omega-3 Fatty Acids

Hani Sabbour,Deepak L. Bhatt, Yaser Elhenawi,Asma Aljaberi, Layal Bennani, Tarek Fiad,Khwaja Hasan,Shahrukh Hashmani, Rabih A. Hijazi, Zafar Khan, Ronney Shantouf

Cardiovascular Drugs and Therapy（2024）

引用 0|浏览0

暂无评分

摘要

Patients with hyperlipidemia treated with statins remain at a residual cardiovascular (CV) risk. Omega-3 polyunsaturated fatty acids hold the potential to mitigate the residual CV risk in statin-treated patients, with persistently elevated triglyceride (TG) levels. We reviewed the current evidence on the use of icosapent ethyl (IPE), an omega-3 fatty acid yielding a pure form of eicosapentaenoic acid. REDUCE-IT reported a significant 25

查看译文

关键词

Hypertriglyceridemia,Dyslipidemia,Residual cardiovascular risk,Omega-3 polyunsaturated fatty acids,Icosapent ethyl,Eicosapentaenoic acid

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要